Episode 270: 269. What is the Harm in Aspirin?
Questioning Medicine
English - April 15, 2024 00:00 - 4 minutes - 5.19 MB - ★★★★★ - 63 ratingsMedicine Health & Fitness health education medicine hospital general family health & fitness Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
The trial was terminated after 1015 patients with atrial cardiopathy had been randomized to receive either apixaban or aspirin for a mean follow-up of 1.8 years, recurrent stroke rates were identical (40 events per group; 4.4% annualized rate). There were 7 symptomatic intracranial hemorrhages in the aspirin group and none in the apixaban group, though other major hemorrhages occurred at similar rates
Aspirin is not benign and has real risk--
BTW don't give anticoagulation if the patient does not have atrial fib.
https://jamanetwork.com/journals/jama/article-abstract/2814933